The future, as it is commonly said, belongs to those who can imagine it, and more to the point it belongs to those who can make it become a reality, here and now. This issue of IMMpress Magazine beautifully showcases innovations in regenerative medicine, with the recent creation of interspecific chimeras, new advances in cancer screening and cancer-fighting bacteria, and the use of nanotechnology in immune modulation or vaccine design. There is a terrific alumni interview and insightful articles on allergy treatments, diet and evolution, and new prosthetic developments. This is a forward-looking issue that also takes stock of the impact of Volume 4 of IMMpress.
Even as we look to the future, I reflect on the past achievements of Kieran Manion, IMMpress Magazine’s outgoing co-Editor in Chief, as the start of Volume 5 also represents her last issue at the editorial helm, along with Angela Zhou. Kieran’s dedication, journalistic flare and editorial acumen will be missed. I am pleased to welcome Sintia Xhiku, a past and current feature article contributor, who will be serving as co-Chief Editor with Angela, who thankfully remains as a guiding force of this extraordinary publication.
As IMMpress Magazine begins its 5th year, my time as chair of the Department of Immunology is nearing the end of its 5-year term. Along with this, the Department underwent a cyclical external review, and I am pleased to say that the reviews were very positive, as were the recommendations. Among the many things that were done in the past 5 years, very few provide me with as much pride and joy as IMMpress.
I hope you enjoy this issue, and the upcoming ones, and importantly whether you are an alumnus of the department, or a prospective student, I really look forward to hearing from you.
IMMpress
Latest posts by IMMpress (see all)
- IMMpress Volume 12 Issue 3 – Death and Senescence - January 20, 2025
- Letter from the Editors – Volume 12 Issue 3, 2025 - January 20, 2025
- IMMpress Volume 12 Issue 2 – Canadian Immunology - October 4, 2024
